The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion device from the internationally renowned surgeon Randal Betz, M.D.’s company, ...
Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –– Patient reported efficacy outcomes ...
The 45-year-old, who has a degenerative spine condition, said the pet helps calm his anxiety, which has worsened since he stopped taking the strong opioid painkiller Tramadol. But the criminology ...
a patient with a spinal-cord tumor; a patient with herpetiform lesions; a patient with healed encephalitis; a patient with a degenerative disease that may have resulted from a cerebrovascular ...
22h
For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...
According to the National Institutes of Health, 8.2% of American adults have chronic severe back pain. Sometimes, the pain ...
Some LIers drawn to Florida no longer want to take the risk. Others see it as a fair trade for summer year-round.
5. Key findings concluded that the use of AMP2, Theradaptive's proprietary adhesive variant of BMP-2, showed healing outcomes equivalent to or better than ICBG. The precise delivery of the protein ...
Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...
Theradaptive, a privately held, clinical stage biologics company developing targeted protein therapeutics for spine, orthopedics, soft tissue repair and targeted immuno-oncology, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback